Vaishali Pharma Limited

NSE VAISHALI.NS

Vaishali Pharma Limited Cash and Short-Term Investments for the year ending March 31, 2024: USD 189.22 K

Vaishali Pharma Limited Cash and Short-Term Investments is USD 189.22 K for the year ending March 31, 2024, a -87.48% change year over year. Cash and short-term investments are the sum of cash and short-term investments, representing the company's liquid assets.

Vaishali Pharma Limited Cash and Short-Term Investments for the year ending March 31, 2023 was USD 1.51 M, a 887.49% change year over year.
Vaishali Pharma Limited Cash and Short-Term Investments for the year ending March 31, 2022 was USD 153.07 K, a 257.53% change year over year.
Vaishali Pharma Limited Cash and Short-Term Investments for the year ending March 31, 2021 was USD 42.81 K, a 13.91% change year over year.
Vaishali Pharma Limited Cash and Short-Term Investments for the year ending March 31, 2020 was USD 37.58 K, a 13.56% change year over year.

Key data

Date	Cash and Short-Term Investments	Receivables	Inventory	Goodwill

NSE: VAISHALI.NS

Vaishali Pharma Limited

CEO	Mr. Hemanth Damodar Pathak
IPO Date	Aug. 22, 2017
Location	India
Headquarters	706 to 709, Aravalli Business Center
Employees	27
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Personal Care Pet Food Plastics

Description

Vaishali Pharma Limited engages in the pharmaceutical business in India and internationally. It offers active pharmaceutical ingredients (APIs), including antibiotics, anti-ulcer, anti-inflammatory/analgesic/anti-pyretic, anti-malarial, cardiac, anti-diabetic, anti-cold/anti-allergic, anti-diarrheal/anti-protozoal/anti-parasitic, anti-viral, anti-epileptic, anti-asthmatic, anti-fungal, anti-platelet agent, skeletal muscle relaxant, and anti-helmintic drugs, as well as excipients, topical steroids, corticosteroids, and enzymes. The company also provides formulation products, such as antibiotics/antibacterial, anti-platelet, laxative, anti-ulcer/enzyme, anti-asthmatic, anti-malarial, anti-cold/anti-allergic/anti-viral, anti-psychotic, anti-fungal, anti-inflammatory/analgesic/anti-pyretic, anti-diabetic, cardiac, vitamins, topical steroids/corticosteroids, and other formulations. In addition, it offers veterinary pharmaceutical, nutraceutical, oncology, herbal, and surgical products. The company was founded in 1989 and is headquartered in Mumbai, India.

Key trends

Past 5 years